Overview

Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3

Status:
Completed
Trial end date:
1997-12-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the safety of lofexidine in the treatment of opiate withdrawal. Preliminary data will also be obtained to assess the ability of lofexidine to alleviate opiate withdrawal signs and symptoms.
Phase:
Phase 1
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborator:
University of Pennsylvania
Treatments:
Clonidine
Lofexidine
Criteria
Please contact site for information.